Everest Medicines Limited
Everest Medicines Limited (HKSE: 1952) is trading at HK$30.14, about ₹369 at today's HKD/INR rate, as of 30 Sep 2026, 4:08 AM ET, up 7.72% today. Indian residents can buy Everest Medicines from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$28.02
Today's high
HK$30.48
52 week low
HK$22.70
52 week high
HK$58.60
1952 opened at HK$28.02, closed previously at HK$27.98, and has traded between HK$22.70 and HK$58.60 over the past 52 weeks.
About
Everest Medicines Limited operates as a biopharmaceutical firm, concentrating its efforts on bringing innovative treatments to market. The company handles the entire process, from identifying and acquiring promising drug candidates to developing them through clinical trials and ultimately commercializing them. Its core objective is to address significant gaps in existing medical treatments within the broader Asia Pacific region, with a particular focus on Greater China. The company boasts a strong portfolio, including eleven experimental drug candidates currently undergoing clinical evaluation. These investigational therapies are designed to combat a range of serious conditions, including various forms of cancer (oncology), immune system disorders (immunology), heart and kidney ailments (cardio-renal), and infectious diseases. Everest Medicines Limited was founded in 2017 and is based in Shanghai, China.
Key statistics
Avg. volume
7.01M
Market cap
HK$10.59B
P/E Ratio
-162.91
Price-to-sales ratio
3.75
Enterprise value
CN¥9.31B
Free cash flow yield
-1.55%
Debt-to-equity ratio
0.38
Return on equity
-5.61%
ROIC
-3.16%
Beta
1.56
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥1.71B
Earnings per share
-CN¥0.89
Free cash flow
-CN¥172.32M
Net profit margin
-2.24%
Gross margin
69.83%
EBITDA
-CN¥211.18M
Revenue growth
141.51%
Similar securities
This is not an investment recommendation
How to buy Everest Medicines from India
Indian residents can buy Everest Medicines shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Everest Medicines and place an order
Find Everest Medicines by name or by its ticker, 1952, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Everest Medicines trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Everest Medicines position in HKD and INR. Everest Medicines pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Everest Medicines from India
Trading and taxes when buying Everest Medicines from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneEverest Medicines does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Everest Medicines stock?
Yes. Everest Medicines (1952) has been listed on the Hong Kong Stock Exchange since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Everest Medicines share cost in rupees?
One Everest Medicines share is HK$30.14 — about ₹369 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the Everest Medicines price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Everest Medicines from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Everest Medicines?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Everest Medicines shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Everest Medicines price. Paasa issues a capital-gains statement for your return.
Does Everest Medicines pay a dividend?
No. Everest Medicines does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Everest Medicines from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Everest Medicines a Hong Kong SAR China company, and does that change how it is taxed?
Everest Medicines trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Everest Medicines trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Everest Medicines shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Everest Medicines holding, its cost and its closing value.
How do I sell Everest Medicines and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.